← Leaderboards
Leslie Anne Parsels
University Of Michigan At Ann Arbor
$718,895
Attributed
$718,895
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $143.8K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$718,895 · 1
By mechanism
R50$718,895 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Theodore S Lawrence$30,022,406
- Randall K Ten Haken$3,907,299
- Meredith A Morgan$5,182,920
- Daniel R Wahl$6,515,358
- James W Russell$3,506,739
Others in their field
Other Emerging Leaders on “Funding”
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lynn Briscoe · Leidos Biomedical Research, Inc.$295,272,057
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$251,636,500
Research focus
FundingFutureAwardDna Repair PathwayAntimetabolitesFlow CytometryBiological MarkersCellular TargetingChemoradiationBioluminescence ImagingClinical TrialsClinical Trials DesignCollaborationsCancer BiologyCell Cycle CheckpointConfocal MicroscopyConformal RadiotherapyDefectDna DamageDna Double Strand BreakClinicDna RepairDna Repair InhibitionGenetic
Grant awards (5)
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response$143,779
R50 · FY2024 · CA · contact PI
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response$143,779
R50 · FY2023 · CA · contact PI
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response$143,779
R50 · FY2022 · CA · contact PI
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response$143,779
R50 · FY2021 · CA · contact PI
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response$143,779
R50 · FY2020 · CA · contact PI